Buccal mucoadhesive films containing antihypertensive drug: In vitro/in vivo evaluation

Journal of Chemical and Pharmaceutical Research

Volumn 3, Issue 6, 2011, Pages 665-686

  Mohamed, Magdy I ^a   Haider, Mohamed ^a   Ali, Muaadh A Mohamed ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Buccal delivery; Chicken pouch membrane; Diltiazem hydrochloride; Mucoadhesive films; Relative bioavailability

Indexed keywords

BUCCAL DELIVERIES; CORRELATION COEFFICIENT; DILTIAZEM HYDROCHLORIDE; HYDROPHILIC AND HYDROPHOBIC; HYDROXYPROPYL CELLULOSE; PHYSICOCHEMICAL CHARACTERISTICS; RELATIVE BIOAVAILABILITY; SODIUM CARBOXYMETHYL CELLULOSE;

ANIMALS; BIOCHEMISTRY; DRUG DELIVERY; POLYMERS;

DRUG PRODUCTS;

ALGINIC ACID; ALTIAZEM RS; CARBOXYMETHYLCELLULOSE; DILTIAZEM; EUDRAGIT; HYDROXYPROPYLCELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE; POLYVINYL ALCOHOL; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DEVELOPMENT; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; HYDROPHILICITY; HYDROPHOBICITY; MALE; MAXIMUM PLASMA CONCENTRATION; MUCOADHESION; NONHUMAN; NORMAL HUMAN; PH; PHYSICAL CHEMISTRY; TABLET DRUG CONTENT UNIFORMITY; TABLET FOLDING ENDURANCE; TABLET PROPERTY; TABLET THICKNESS; TABLET WEIGHT; WEIGHT;

EID: 84875201765     PISSN: None     EISSN: 09757384     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. A H Shojaeei, J Pharm Pharmaceut Sci 1998, 1(1), 15-30.
2. H Zhang; J Zhang and J B Streisand, Clin Pharmacokinet, 2002, 41(9), 661-680.
3. N V Madhav; A K Shakya; P Shakya and K Singh, J Control Release, 2009, 140(1), 2-11.
4. H Choi; J Jung; C S Yong; C Rhee; M Lee; J Han; K Park and C Kim, J Control Release, 2000, 68(3), 405-412.
5. G Shanker; C K Kumar; C S Gonugunta; B V Kumar and P R Veerareddy, AAPS PharmSciTech, 2009, 10(2), 530-539.
6. M Ishida; N Nambu and T Nagai, Chem Pharm Bull (Tokyo), 1983, 31(12), 4561-4564.
7. S J Sveinsson and P W Holbrook, Int J Pharm, 1993, 95105-109.
8. S Singh; S Jain; M S Muthu; S Tiwari and R Tilak, AAPS PharmSciTech, 2008, 9(2), 660-667.
9. H Okamoto; H Taguchi; K Iida and K Danjo, J Control Release, 2001, 77(3), 253-260.
10. L Perioli; V Ambrogi; F Angelici; M Ricci; S Giovagnoli; M Capuccella and C Rossi, J Control Release, 2004, 99(1), 73-82.
11. C Timothy and M D Fagan, Clin Cardiol, 2003, 26, 1-4.
12. M Chaffman and R N Brogden, Drugs, 1985, 29(5), 387-454.
13. P Hermann; S D Rodger; G Remones; J P Thenot; D R London and P L Morselli, Eur J Clin Pharmacol, 1983, 24(3), 349-352.
14. A Kokate; X Li; P J Williams; P Singh and B R Jasti, Pharm Res, 2009, 26(5), 1130-1139.
15. C F Wong; K H Yuen and K K Peh, Int J Pharm, 1999, 178(1), 11-22.
16. S Senel; G Ikinci; S Kas; A Yousefi-Rad; M F Sargon and A A Hincal, Int J Pharm, 2000, 193(2), 197-203.
17. V M Patel; B G Prajapati and M M Patel, AAPS PharmSciTech, 2007, 8(2), Article 45.
18. P Bottenberg; R Cleymaet; C de Muynck; J P Remon; D Coomans; Y Michotte and D Slop, J Pharm Pharmacol, 1991, 43(7), 457-464.
19. A Sood and R Panchagnula, Int J Pharm, 1998, 175, 95-107.
20. K G Desai and T M Kumar, AAPS PharmSciTech, 2004, 5(3), e35.
21. S A Yehia; O N El-Gazayerly and E B Basalious, Curr Drug Deliv, 2009, 6(1), 17-27.
22. M Kerec; M Bogataj; B Mugerle; M Gasperlin and A Mrhar, Int J Pharm, 2002, 241(1), 135-143.
23. J Ali; R Khar; A Ahuja and R Kalra, Int J Pharm, 2002, 238(1-2), 93-103.
24. M S El-Samaligy; S A Yahia and E B Basalious, Int J Pharm, 2004, 286(1-2), 27-39.
25. C F Wong; K H Yuen and K K Peh, Int J Pharm, 1999, 180(1), 47-57.
26. S A Tayel; Soliman, II and D Louis, AAPS PharmSciTech, 2010, 11(2), 679-685.
27. V De Caro; G Giandalia; M G Siragusa; C Paderni; G Campisi and L I Giannola, Eur J Pharm Biopharm, 2008, 70(3), 869-873.
28. H H Alur; S I Pather; A K Mitra and T P Johnston, Int J Pharm, 1999, 188(1), 1-10.
29. V M Patel; B G Prajapati; J K Patel and M M Patel, Curr Drug Deliv, 2006, 3(3), 325-331.
30. M Semalty; A Semalty and G Kumar, Indian J Pharm Sci, 2008, 70(1), 43-48.
31. N B Dobaria; A C Badhan and R C Mashru, AAPS PharmSciTech, 2009, 10(3), 951-959.
32. A M Mumtaz and H S Ch'ng, Int J Pharm, 1995, 121, 129-139.
33. T H Kim; J S Ahn; H K Choi; Y J Choi and C S Cho, Arch Pharm Res, 2007, 30(3), 381-386.
34. T Pongjanyakul and H Suksri, Colloids Surf B Biointerfaces, 2009, 74(1), 103-113.
35. C Eouani; P Piccerelle; P Prinderre; E Bourret and J Joachim, Eur J Pharm Biopharm, 2001, 52(1), 45-55.
36. P Mura; G Corti; M Cirri; F Maestrelli; N Mennini and M Bragagni, J Pharm Sci, 2010, 99(7), 3019-3029.
37. K C Sekhar; K V Naidu; Y V Vishnu; R Gannu; V Kishan and Y M Rao, Drug Deliv, 2008, 15(3), 185-191.
38. Y V Vishnu; K Chandrasekhar; G Ramesh and Y M Rao, Curr Drug Deliv, 2007, 4(1), 27-39.
39. V A Perumal; D Lutchman; I Mackraj and T Govender, Int J Pharm, 2008, 358(1-2), 184-191.
40. R Bodmeier and O Paeratakul, Pharm Res, 1989, 6(8), 725-730.
41. J M Llabot; S D Palma; R H Manzo and D A Allemandi, Int J Pharm, 2007, 336(2), 263-268.
42. N A Peppas, Pharm Acta Helv, 1985, 60(4), 110-111.
43. R W Korsmeyer; R Gurny; E Doelker; P Buri and N A Peppas, Int J Pharm, 1983, 15, 25-35.
44. M Nappinnai; R Chandanbala and R Balaijirajan, Indian J Pharm Sci, 2008, 70(5), 631-635.